Related Experiment Video
Updated: Jun 22, 2026
2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia
Published on: June 22, 2013
The Effects of Atorvastatin on Global Cerebral Ischemia-Induced Neuronal Death
A Ra Kho1, Dae Ki Hong1, Beom Seok Kang1
1Department of Physiology, College of Medicine, Hallym University, Chuncheon 24252, Korea.
Insights
Atorvastatin demonstrates neuroprotective effects, reducing neuronal death and improving cognitive function in rats following global cerebral ischemia (GCI). This suggests atorvastatin as a potential therapeutic option for managing GCI.
Area of Science:
- Neuroscience
- Pharmacology
- Cardiovascular Research
Background:
- Global cerebral ischemia (GCI) causes severe hypoxic brain damage, leading to mortality and long-term disability.
- Early blood reperfusion does not always prevent significant neurological deficits after GCI.
Purpose of the Study:
- To investigate the neuroprotective potential of atorvastatin in a rat model of global cerebral ischemia.
- To evaluate the effects of atorvastatin on neuronal survival, oxidative stress, inflammation, and cognitive function post-GCI.
Main Methods:
- Rats were treated with atorvastatin (ATOR) or vehicle (Veh) orally for acute (1-week) and chronic (4-week) periods after inducing GCI.
- Histological analyses included Fluoro-Jade B, NeuN, 4-hydroxynonenal, CD11b, GFAP, IgG, SMI71, and vWF staining.
- Cognitive function was assessed using a battery of behavioral tests.
Main Results:
- Atorvastatin treatment significantly reduced neuronal death, oxidative stress, inflammation, and blood-brain barrier (BBB) disruption compared to vehicle control.
- Endothelial damage and white matter (VV) proliferation were decreased in the atorvastatin group.
- Significant improvements in cognitive function were observed in the atorvastatin-treated GCI rats.
Conclusions:
- Atorvastatin exhibits significant neuroprotective effects in a rat model of global cerebral ischemia.
- Atorvastatin administration aids in the recovery of cognitive function after GCI.
- Atorvastatin may represent a viable therapeutic strategy for managing patients experiencing GCI after cardiac arrest (CA).
Abstract:
(1) Background and Purpose: Global cerebral ischemia-induced severe hypoxic brain damage is one of the main causes of mortality and long-term neurologic disability even after receiving early blood reperfusion. This study aimed to test the hypothesis that atorvastatin potentially has neuroprotective effects in global cerebral ischemia (GCI). (2) Methods: We performed two sets of experiments, analyzing acute (1-week) and chronic (4-week) treatments. For the vehicle (Veh) and statin treatments, 1 mL of 0.9% saline and 5 mg/kg of atorvastatin (ATOR) were administered orally. For histological analysis, we used the following staining protocols: Fluoro-Jade B and NeuN, 4-hydroxynonenal, CD11b and GFAP, IgG, SMI71, and vWF. Finally, we evaluated the cognitive function with a battery of behavioral tests. (3) Results: The GCI-ATOR group showed significantly reduced neuronal death, oxidative stress, inflammation, and BBB disruption compared with the GCI-Veh group. Moreover, the GCI-ATOR group showed decreased endothelial damage and VV proliferation and had significantly improved cognitive function compared with the GCI-Veh group in both models. (4) Conclusions: ATOR has neuroprotective effects and helps recover the cognitive function after GCI in rats. Therefore, administration of atorvastatin may be a therapeutic option in managing GCI after CA.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
01:15Ischemic Stroke ll: Pathophysiology